Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive tags : Technology save search
Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
Published: 2024-04-16 (Crawled : 16:00) - biospace.com/
PTPI | $0.6849 -1.86% -1.9% 150K
|
|
| O: 9.85%
H: 4.63%
C: -18.04%
fda positive pharmaceuticals for technology response
Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego
Published: 2024-03-28 (Crawled : 12:30) - globenewswire.com
NXL | $1.44 -2.04% -2.08% 260K
|
|
| O: 8.99%
H: 0.0%
C: 0.0%
device positive technology results study
Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
Published: 2024-03-06 (Crawled : 13:30) - globenewswire.com
NXL | $1.44 -2.04% -2.08% 260K
|
|
| O: -1.61%
H: 95.85%
C: 52.0%
device positive technology results study
NaaS Technology Inc. Announces Positive NTR for January 2024 and Updates Revenue Guidance for Full Year 2023
Published: 2024-02-08 (Crawled : 13:30) - prnewswire.com
NAAS | $0.9903 -3.85% -4.01% 780K
|
|
| O: 0.55%
H: 10.44%
C: 4.4%
year revenue positive technology
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform
Published: 2024-01-05 (Crawled : 13:30) - biospace.com/
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 0.71%
H: 4.24%
C: 2.12%
covid-19 vaccine positive collaboration program technology platform
Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression
Published: 2023-12-18 (Crawled : 13:30) - globenewswire.com
NXL | $1.44 -2.04% -2.08% 260K
|
|
| O: 5.26%
H: 10.52%
C: -2.5%
device positive depression technology results study benefits
SunHydrogen Well-Positioned to Scale Technology From Lab-Scale to a 1m2 Green Hydrogen Panel
Published: 2023-11-07 (Crawled : 11:00) - globenewswire.com
HYSR | $0.014 -39.79% 6.5M
|
Manufacturing
|
| O: 5.79%
H: 8.59%
C: 3.13%
technology hydrogen
Vuzix Advances its Leadership Position in Waveguide Performance with New Vuzix INCOGNITO Technology
Published: 2023-11-06 (Crawled : 14:30) - prnewswire.com
VUZI P | $1.19 -5.56% -5.88% 550K
|
Electronic Technology
|
| O: -0.57%
H: 1.71%
C: -4.13%
technology
Positive Topline Results Reported from Bristol Myers Squibb's Phase 3 CheckMate-67T Trial of Subcutaneous Nivolumab with Halozyme's ENHANZE® Drug Delivery Technology for Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Published: 2023-10-19 (Crawled : 12:00) - biospace.com/
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 0.95%
H: 0.41%
C: -1.27%
enhanze drug nivolumab renal positive cell topline technology trial results
MIND Technology Announces Positioning System Orders
Published: 2023-10-03 (Crawled : 21:00) - prnewswire.com
MIND | $4.07 3.94% 1.3K
|
Industrial Services
|
| O: 4.98%
H: 0.0%
C: -2.61%
system technology
Proterra Announces Strategic Initiatives to Strengthen Financial Position and Sharpen Technology Focus
Published: 2023-08-07 (Crawled : 22:00) - globenewswire.com
PTRA | $0.067 -25.56% -34.33% 58M
|
Manufacturing
|
| O: -69.03%
H: 0.0%
C: 0.0%
MC | $51.65 1.33% 0.0% 590K
|
Finance
|
| O: -0.83%
H: 0.06%
C: -0.52%
technology proterra financial
Sight Sciences Announces Positive Results and Primary Endpoint Successfully Met in SAHARA, a Randomized Controlled Clinical Trial Comparing Interventional Eyelid Procedures Enabled by TearCare® Technology to Restasis¹ for the Treatment of Dry Eye
Published: 2023-07-20 (Crawled : 12:00) - globenewswire.com
SGHT | $5.14 -1.91% -1.95% 130K
|
|
| O: 0.52%
H: 1.68%
C: -4.39%
tearcare positive treatment sciences eye technology trial results
Positive Topline Data Reported from argenx's ADHERE Study of VYVGART® Hytrulo with Halozyme's ENHANZE® Drug Delivery Technology in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
Published: 2023-07-17 (Crawled : 06:00) - prnewswire.com
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 1.36%
H: 7.29%
C: 3.95%
vyvgart drug positive topline technology study
Positive Results Announced from Phase 3 OCARINA II Trial Evaluating Roche's OCREVUS® (ocrelizumab) with Halozyme's ENHANZE® Drug Delivery Technology in Patients with Multiple Sclerosis
Published: 2023-07-13 (Crawled : 06:00) - prnewswire.com
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 0.97%
H: 5.14%
C: 4.42%
ocrevus drug positive sclerosis technology trial results
Maxeon Solar Technologies Extends Solar Panel Technology Leadership Position
Published: 2023-06-01 (Crawled : 20:00) - prnewswire.com
MAXN | News | $1.805 -5.74% -6.09% 3.9M
|
Utilities
|
| O: 1.62%
H: 1.69%
C: -3.19%
solar technology
Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line
Published: 2023-05-18 (Crawled : 22:00) - biospace.com/
CELZ | $4.82 0.21% 0.21% 22K
|
|
| O: 6.06%
H: 2.71%
C: -15.41%
stemspine back positive cell medical technology results study
Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
Published: 2023-04-17 (Crawled : 18:00) - biospace.com/
TNDM | $30.445 -1.57% -1.59% 990K
|
Health Technology
|
| O: 1.21%
H: 0.24%
C: -0.55%
DXCM | $130.71 -2.67% -2.75% 2.8M
|
Health Technology
|
| O: 1.91%
H: 1.95%
C: 0.63%
control positive care automatic impact technology diabetes
Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study
Published: 2023-04-12 (Crawled : 18:00) - biospace.com/
CELZ | $4.82 0.21% 0.21% 22K
|
|
| O: 160.33%
H: 5.56%
C: -30.56%
positive medical technology diabetes results study
Kraig Biocraft Laboratories Adds Two New Positions on Research Team to Accelerate Implementation of its Spider Silk Technology Roadmap
Published: 2023-02-28 (Crawled : 12:00) - globenewswire.com
KBLB | $0.088 -0.63% 350K
|
Mining, Quarrying, and Oil and ...
|
| O: -4.86%
H: 11.65%
C: 10.51%
research technology
Virpax Announces Positive Preclinical Toxicology Results in Support of Molecular Envelope Technology (MET)
Published: 2023-02-13 (Crawled : 16:00) - biospace.com/
VRPX | $3.86 -4.46% -4.66% 6K
|
|
| O: 4.72%
H: 0.0%
C: -0.9%
preclinical virpax technology positive results molecular
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.